Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Emergent Biosolutions (EBS)

Emergent Biosolutions (EBS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,403,183
  • Shares Outstanding, K 53,585
  • Annual Sales, $ 1,555 M
  • Annual Income, $ 305,100 K
  • 60-Month Beta 1.01
  • Price/Sales 2.26
  • Price/Cash Flow 6.40
  • Price/Book 2.30
Trade EBS with:

Options Overview

Details
  • Implied Volatility 44.06%
  • Historical Volatility 42.98%
  • IV Percentile 1%
  • IV Rank 1.43%
  • IV High 109.35% on 11/03/20
  • IV Low 43.11% on 05/27/21
  • Put/Call Vol Ratio 0.28
  • Today's Volume 463
  • Volume Avg (30-Day) 732
  • Put/Call OI Ratio 0.58
  • Today's Open Interest 12,441
  • Open Int (30-Day) 12,539

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 1.81
  • Number of Estimates 2
  • High Estimate 2.03
  • Low Estimate 1.59
  • Prior Year 1.98
  • Growth Rate Est. (year over year) -8.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
55.85 +13.73%
on 05/19/21
66.22 -4.09%
on 06/07/21
+4.71 (+8.01%)
since 05/11/21
3-Month
55.07 +15.33%
on 05/11/21
96.03 -33.86%
on 03/22/21
-28.39 (-30.89%)
since 03/11/21
52-Week
55.07 +15.33%
on 05/11/21
137.61 -53.85%
on 08/06/20
-4.60 (-6.75%)
since 06/11/20

Most Recent Stories

More News
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of June 18, 2021 - EBS

New York, New York--(Newsfile Corp. - June 14, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:

EBS : 63.51 (-3.01%)
EBS 5-DAY DEADLINE ALERT: Hagens Berman Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Before June 18th Deadline in Securities Fraud Lawsuit

San Francisco, California--(Newsfile Corp. - June 13, 2021) - Hagens Berman urges Emergent BioSolutions Inc. investors with $100k or more losses to .

EBS : 63.51 (-3.01%)
CLASS ACTION UPDATE for ACAD, EBS and ATER: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / June 13, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders...

ACAD : 27.42 (+0.44%)
EBS : 63.51 (-3.01%)
ATER : 15.81 (+0.70%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Emergent BioSolutions Inc. - EBS

New York, New York--(Newsfile Corp. - June 12, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Emergent BioSolutions Inc. ("Emergent" or the "Company") (NYSE: EBS). Such investors...

EBS : 63.51 (-3.01%)
Deadline Alert: Kessler Topaz Meltzer & Check, LLP Alerts Investors of Deadline in Securities Fraud Class Action Lawsuit Against Emergent BioSolutions Inc.

Radnor, Pennsylvania--(Newsfile Corp. - June 12, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP announces that Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action against...

EBS : 63.51 (-3.01%)
EBS 6-DAY DEADLINE ALERT: Hagens Berman Encourages Emergent BioSolutions (EBS) Investors to Contact the Firm Before June 18th Deadline in Securities Fraud Action

Hagens Berman urges Emergent BioSolutions Inc. (NYSE: EBS) investors with $100k or more losses to submit your losses now.

EBS : 63.51 (-3.01%)
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ACAD, EBS and DNMR

NEW YORK, NY / ACCESSWIRE / June 11, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate...

ACAD : 27.42 (+0.44%)
EBS : 63.51 (-3.01%)
DNMR : 24.81 (-0.08%)
FINAL DEADLINE NEXT WEEK: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent BioSolutions Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / June 11, 2021 / , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Emergent BioSolutions Inc. ('Emergent BioSolutions' or...

EBS : 63.51 (-3.01%)
COVID-19 Vaccine Drug Substance Manufactured by Emergent BioSolutions Authorized as Part of Johnson & Johnson's Emergency Use Authorization

-- Emergent continues to work with the FDA to address identified observations at Bayview facility in order to release additional batches and resume production

EBS : 63.51 (-3.01%)
SHAREHOLDER ALERT: ACAD EBS PCT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / June 11, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss...

ACAD : 27.42 (+0.44%)
EBS : 63.51 (-3.01%)
PCT : 19.65 (+2.88%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Emergent BioSolutions Inc. is strongly committed to the highest standards of ethical conduct and corporate governance. These standards are consistent with their corporate culture. The company understands that adhering to sound principles of corporate governance is critical to earning and maintaining...

See More

Key Turning Points

3rd Resistance Point 68.91
2nd Resistance Point 67.52
1st Resistance Point 65.51
Last Price 63.51
1st Support Level 62.11
2nd Support Level 60.72
3rd Support Level 58.71

See More

52-Week High 137.61
Fibonacci 61.8% 106.08
Fibonacci 50% 96.34
Fibonacci 38.2% 86.60
Last Price 63.51
52-Week Low 55.07

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar